Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Teratocarcinoma
Reports outline teratocarcinoma research from U. Silván and colleagues
July 13th, 2009
Investigators publish new data in the report 'Angiogenesis and vascular network of teratocarcinoma from embryonic stem cell transplant into seminiferous tubules.' "Carcinoma in situ (CIS) of the testis is considered to be a precancerous germinal cell lesion, but the precise cellular and molecular mechanisms underlying transformation of CIS into invasive pluripotent cancer cells remain to be elucidated. Moreover, a satisfactory animal model for the experimental study of germinal tumours has not been developed to date," researchers in Spain report. "We have developed a tumor model that involves the microinjection of green fluorescent protein-labelled embryonic stem (ES)...
Source: Biotech Business Week (2009-07-13)
|
